Hemostatic/fibrinolytic protein changes in C3H/HeN mice infected with Rickettsia conorii: A model for Rocky Mountain spotted fever

Thrombosis and Haemostasis

Volumn 86, Issue 3, 2001, Pages 871-879

  Schmaier, A H ^a   Srikanth, S ^a   Elghetany, M T ^a   Normolle, D ^a   Gokhale, S ^a   Feng, H M ^a   Walker, D H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Endothelium; Plasminogen activator inhibitor; Rickettsial disease; Rocky Mountain spotted fever; Tissue plasminogen activator

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; FIBRINOLYTIC FACTOR; HIGH MOLECULAR WEIGHT KININOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PREKALLIKREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONCENTRATION (PARAMETERS); ENDOTHELIUM; ENDOTHELIUM INJURY; FATALITY; HISTOPATHOLOGY; MICROSCOPY; MOUSE; NONHUMAN; PLASMA; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RICKETTSIA CONORII; RICKETTSIOSIS; ROCKY MOUNTAIN SPOTTED FEVER; SURVIVAL;

EID: 0034846361     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616145     Document Type: Article

References (61)

1. Studies on Rocky Mountain spotted fever
2. Rickettsial infection of the pulmonary microcirculation: The basis for interstitial pneumonitis in Rocky Mountain spotted fever
3. Acute renal failure in Rocky Mountain spotted fever
4. Meningoencephalitis as a major manifestation of Rocky Mountain spotted fever
5. Pathology of typhus in man
6. Immunohistochemical diagnosis of typhus rickettsioses using an anti-lipopolysaccharide monoclonal antibody
7. Correlation of the distribution of Rickettsia conorii, microscopic lesions, and clinical features in South African tick bite fever
8. Histopathology and immunohistologic demonstration of the distribution of Rickettsia typhi in fatal murine typhus
9. Characterization of rickettsial attachment to host cells by flow cytometry
10. rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells
11. Rickettsial interactions with human endothelial cells in vitro: Adherence and entry
12. Rickettsia rickettsii infection in cultured human endothelial cells induces NK-κB activation
13. NK-κB-dependent inhibition of apoptosis is essential for host cell survival during Rickettsia rickettsii infection
14. Proteasome-independent activation of nuclear factor κB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii
15. Potential for free radical-induced lipid peroxidation as a cause of endothelial cell injury in Rocky Mountain spotted fever
16. A potential protective role for thiols against cell injury caused by Rickettsia rickettsii
17. Heparin protects human endothelial cells infected by Rickettsia rickettsii
18. Rickettsia rickettsii induces superoxide radical and superoxide dismutase in human endothelial cells
19. Infection of human endothelial cells by Rickettsia rickettsii causes a significant reduction in the levels of key enzymes involved in protection against oxidative injury
20. Effects of the antioxidant α-lipoic acid on human umbilical vein endothelial cells infected with Rickettsia rickettsii
21. Role of phospholipase-associated penetration mechanism in cell injury by Rickettsia rickettsii
22. Penetration of host cells by Rickettsia rickettsii appears to be mediated by a phospholipase of rickettsial origin
23. Rickettsial diseases
24. Rickettsia rickettsii infection of cultured human endothelial cells induces tissue factor expression
25. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever
26. Defibrination syndrome in Rocky Mountain spotted fever: A case report with heparin therapy
27. Hypofibrinogenemia in Rocky Mountain spotted fever. Report of a case
28. Disseminated intravascular coagulation in Rocky Mountain spotted fever
29. Vascular permeability and coagulation during Rickettsia rickettsii infection in dogs
30. Studies of the coagulation and complement systems during experimental Rocky Mountain spotted fever in rhesus monkeys
31. Coagulation abnormalities in patients with Mediterranean spotted fever
32. Kinin-prekallikrein system in Mediterranean spotted fever
33. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever
34. Fibrinolytic changes during acute vascular damage induced by Mediterranean spotted fever
35. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever
36. Demonstration of Rickettsia conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever
37. Rickettsia conorii infection enhances vascular cell adhesion molecule-1- and intercellular adhesion molecule-1-dependent mononuclear cell adherence to endothelial cells
38. Rickettsial stimulation of endothelial platelet-activating factor synthesis
39. Von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells
40. Rickettsia rickettsii infection of cultured endothelial cells induces release of large von Willebrand factor multimers from Weibel-Palade bodies
41. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells
42. Increased expression of plasminogen activator inhibitor-1 in R. rickettsii-infected endothelial cells
43. Functional and morphologic changes during experimental Rocky Mountain spotted fever in guinea pigs
44. Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever
45. Rickettsia conorii infection of C3H/HeN mice a model of endothelial-target rickettsiosis
46. Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: Impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease
47. Role of T-lymphocyte subsets in immunity to spotted fever group rickettsiae
48. Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection
49. Protease nexin-2/amyloid β protein precursor. A tight-binding inhibitor of coagulation factor IXa
50. Evaluation of a functional microassay for determination of plasma prekallikrein
51. Heparin cofactor activity measured with an amidolytic method
52. Characterization of the murine plasma fibrinolytic system
53. Transcriptional regulation of endothelial cell tissue factor expression during Rickettsia rickettsii infection: Involvement of the transcriptional factor NF-kappaB
54. Increased expression of plasminogen activator inhibitor-1 in Rickettsia rickettsii-infected endothelial cells
55. Interleukin-1α production during Rickettsia rickettsii infection of cultured endothelial cells: Potential role in autocrine cell stimulation
56. Further studies on the hypercoagulable state of patients with Cushing's syndrome
57. Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury
58. Factor XI activation in a revised model of blood coagulation
59. Thrombin-mediate feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa
60. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats
61. Assay of prekallikrein in human plasma: Comparison of amidolytic, esterolytic, coagulation, and immunochemical assays